+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Medicine Market by Product, Route of Administration, Animal Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • PDF Icon

    Report

  • 307 Pages
  • July 2020
  • Region: Global
  • Allied Market Research
  • ID: 5141664
The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6% from 2020 to 2027. Veterinary medicine is defined as a drug or other preparations employed in the treatment of animals. Furthermore, other preparations such as vaccines and medicated feed additives are also used to treat various medical conditions in animals. In addition, these medicines include different type of products such as anti-infective drugs, which are used to prevent, kill, or slow the growth of bacteria, fungi and other infection causing organisms. These medicines also include anti-inflammatory drugs, which are routinely used for relief of pain and inflammation associated with osteoarthritis, and other medical conditions in livestock and companion animals. Furthermore, parasiticide is another type of veterinary drug, which are employed in prevention or elimination of external and internal parasites such as fleas, ticks, and worms. Other than drugs, vaccines are also used in treatment of various medical conditions in animals. Some types of veterinary vaccines include inactivated vaccines, attenuated vaccines, and recombinant vaccine.

Similarly, medicated feed additives are also used to cure medical conditions in livestock and companion animals. In addition, these different types of drugs are administered to animals through different routes such as oral, parenteral and topical. Furthermore, these drugs are used in treatment of companion animals such as dogs, cats and horses and are also used in treatment of livestock animals such as pigs, dairy cattle, beef cattle, and poultry.

The major factors that contribute toward the growth of the veterinary medicine market include rise in number of pet owners and surge in livestock population across the globe. Furthermore, factors such as surge in prevalence of various medical conditions in animals and rise in demand for livestock products also boost growth of the veterinary medicine market. In addition, the rise in animal healthcare expenditure is another major factor that fuels growth of the market. However, the lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicate feed additives restrict growth of the veterinary medicine market. Conversely, increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market.

The global veterinary medicine market is segmented on the basis of product, route of administration, animal type, distribution channel, and region to provide a detailed assessment of the market. By product, the market is divided into drugs, vaccines, and medicated feed additives. The drugs segment is further divided into anti-infective, anti-inflammatory, and parasiticide. In addition, the vaccines segment is divided into inactivated vaccines, attenuated vaccines, and recombinant vaccines. Similarly, the medicated feed additives segment is divided into amino acids and antibiotics. By route of administration, the market is classified into oral route, parenteral route, and topical route. By animal type, it is divided into companion animals and livestock animals. By distribution channel, it is classified into veterinary hospitals, veterinary clinics, and pharmacies & drug stores. By region, the veterinary medicine market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The major players in the veterinary medicine market are Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Santé Animale, Virbac., Vetoquinol S.A., Boehringer Ingelheim International GmbH., ADM Animal Nutrition, and Evonik Industries AG.

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global negative pressure wound therapy devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Product
  • Drugs
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Medicated Feed Additives
  • Amino Acids
  • Antibiotics

By Route of Administration
  • Oral Route
  • Parenteral Route
  • Topical Route

By Route of Administration
  • Oral Route
  • Parenteral Route
  • Topical Route

By Animal Type
  • Companion Animals
  • Livestock Animals

By Distribution Channel
  • Veterinary Hospital Pharmacies
  • Retail Veterinary Pharmacies

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
- List of key players profiled in the report:
  • Zoetis, Inc.
  • Merck & Co., Inc. (Intervet International B.V.)
  • Elanco Animal Health
  • Dechra Pharmaceuticals PLC
  • Ceva Santé Animale
  • Virbac.
  • Vetoquinol S.A.
  • Boehringer Ingelheim International GmbH.
  • ADM Animal Nutrition
  • Evonik Industries AG

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • Pharmgate Inc.
  • Bimedia, Inc.

Table of Contents

Chapter 1. Introduction
1.1. Report Description
1.2. Key Market Segments
1.2.1. List of Key Players Profiled in the Report
1.3. Research Methodology
1.3.1. Primary Research
1.3.2. Secondary Research
1.3.3. Analyst Tools and Models
Chapter 2. Executive Summary
2.1. Key Findings of the Study
2.2. CXO Perspective
Chapter 3. Market Overview
3.1. Market Definition and Scope
3.2. Top Player Positioning
3.2.1. Top Investment Pockets
3.3. Key Forces Shaping Veterinary Medicines Industry/Market
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Surge in Ownership of Companion Animals
3.4.1.2. Rise in Livestock Population Across the Globe
3.4.1.3. Rise in Animal Healthcare Expenditure
3.4.1.4. Surge in Prevalence of Various Medical Conditions in Animals
3.4.2. Restraint
3.4.2.1. Stringent Regulatory Approvals Related to Veterinary Drugs and Vaccines
3.4.2.2. Lack of Veterinary Infrastructure Facilities in Underdeveloped Nations
3.4.3. Opportunity
3.4.3.1. Surge in Awareness Related to Animal Healthcare
3.4.4. Impact Analyses
3.5. Covid-19 Impact Analysis on Global Veterinary Medicine Market
Chapter 4. Veterinary Medicine Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Drugs
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Type
4.2.2.1. Anti-Infective
4.2.2.1.1. Market Size and Forecast
4.2.2.2. Anti-Inflammatory
4.2.2.2.1. Market Size and Forecast
4.2.2.3. Parasiticide
4.2.2.3.1. Market Size and Forecast
4.2.3. Market Size and Forecast, by Region
4.2.4. Market Analysis, by Country
4.3. Vaccines
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Type
4.3.2.1. Inactivated Vaccines
4.3.2.1.1. Market Size and Forecast
4.3.2.2. Attenuated Vaccines
4.3.2.2.1. Market Size and Forecast
4.3.2.3. Recombinant Vaccines
4.3.2.3.1. Market Size and Forecast
4.3.3. Market Size and Forecast, by Region
4.3.4. Market Analysis, by Country
4.4. Medicated Feed Additives
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Type
4.4.2.1. Amino Acids
4.4.2.1.1. Market Size and Forecast
4.4.2.2. Antibiotics
4.4.2.2.1. Market Size and Forecast
4.4.3. Market Size and Forecast, by Region
4.4.4. Market Analysis, by Country
Chapter 5. Veterinary Medicine Market, by Route of Adminstration
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Oral Route
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis by Country
5.3. Parenteral Route
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis by Country
5.4. Topical Route
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis by Country
Chapter 6. Veterinary Medicine Market, by Animal Type
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Companion Animal
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Livestock Animals
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
Chapter 7. Veterinary Medicine Market, by Distribution Channel
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Veterinary Hospital Pharmacies
7.2.1. Market Size and Forecast, by Region
7.2.2. Market Analysis, by Country
7.3. Retail Veterinary Pharmacies
7.3.1. Market Size and Forecast, by Region
7.3.2. Market Analysis, by Country
Chapter 8. Veterinary Medicine Market, by Region
8.1. Overview
8.1.1. Market Size and Forecast
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Analysis, by Country
8.2.2.1. U.S.
8.2.2.1.1. U.S. Market Size and Forecast, by Product
8.2.2.1.2. U.S. Market Size and Forecast, by Route of Administration
8.2.2.1.3. U.S. Market Size and Forecast, by Animal Type
8.2.2.1.4. U.S. Market Size and Forecast, by Distribution Channel
8.2.2.2. Canada
8.2.2.2.1. Canada Market Size and Forecast, by Product
8.2.2.2.2. Canada Market Size and Forecast, by Route of Administration
8.2.2.2.3. Canada Market Size and Forecast, by Animal Type
8.2.2.2.4. Canada Market Size and Forecast, by Distribution Channel
8.2.2.3. Mexico
8.2.2.3.1. Mexico Market Size and Forecast, by Product
8.2.2.3.2. Mexico Market Size and Forecast, by Route of Administration
8.2.2.3.3. Mexico Market Size and Forecast, by Animal Type
8.2.2.3.4. Mexico Market Size and Forecast, by Distribution Channel
8.2.3. North America Market Size and Forecast, by Product
8.2.4. North America Market Size and Forecast, by Route of Administration
8.2.5. North America Market Size and Forecast, by Animal Type
8.2.6. North America Market Size and Forecast, by Distribution Channel
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Analysis, by Country
8.3.2.1. Germany
8.3.2.1.1. Germany Market Size and Forecast, by Product
8.3.2.1.2. Germany Market Size and Forecast, by Route of Administration
8.3.2.1.3. Germany Market Size and Forecast, by Animal Type
8.3.2.1.4. Germany Market Size and Forecast, by Distribution Channel
8.3.2.2. France
8.3.2.2.1. France Market Size and Forecast, by Product
8.3.2.2.2. France Market Size and Forecast, by Route of Administration
8.3.2.2.3. France Market Size and Forecast, by Animal Type
8.3.2.2.4. France Market Size and Forecast, by Distribution Channel
8.3.2.3. UK
8.3.2.3.1. UK Market Size and Forecast, by Product
8.3.2.3.2. UK Market Size and Forecast, by Route of Administration
8.3.2.3.3. UK Market Size and Forecast, by Animal Type
8.3.2.3.4. UK Market Size and Forecast, by Distribution Channel
8.3.2.4. Italy
8.3.2.4.1. Italy Market Size and Forecast, by Product
8.3.2.4.2. Italy Market Size and Forecast, by Route of Administration
8.3.2.4.3. Italy Market Size and Forecast, by Animal Type
8.3.2.4.4. Italy Market Size and Forecast, by Distribution Channel
8.3.2.5. Spain
8.3.2.5.1. Spain Market Size and Forecast, by Product
8.3.2.5.2. Spain Market Size and Forecast, by Route of Administration
8.3.2.5.3. Spain Market Size and Forecast, by Animal Type
8.3.2.5.4. Spain Market Size and Forecast, by Distribution Channel
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe Market Size and Forecast, by Product
8.3.2.6.2. Rest of Europe Market Size and Forecast, by Route of Administration
8.3.2.6.3. Rest of Europe Market Size and Forecast, by Animal Type
8.3.2.6.4. Rest of Europe Market Size and Forecast, by Distribution Channel
8.3.3. Europe Market Size and Forecast, by Product
8.3.4. Europe Market Size and Forecast, by Route of Administration
8.3.5. Europe Market Size and Forecast, by Animal Type
8.3.6. Europe Market Size and Forecast, by Distribution Channel
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Analysis, by Country
8.4.2.1. Japan
8.4.2.1.1. Japan Market Size and Forecast, by Product
8.4.2.1.2. Japan Market Size and Forecast, by Route of Administration
8.4.2.1.3. Japan Market Size and Forecast, by Animal Type
8.4.2.1.4. Japan Market Size and Forecast, by Distribution Channel
8.4.2.2. China
8.4.2.2.1. China Market Size and Forecast, by Product
8.4.2.2.2. China Market Size and Forecast, by Route of Administration
8.4.2.2.3. China Market Size and Forecast, by Animal Type
8.4.2.2.4. China Market Size and Forecast, by Distribution Channel
8.4.2.3. Australia
8.4.2.3.1. Australia Market Size and Forecast, by Product
8.4.2.3.2. Australia Market Size and Forecast, by Route of Administration
8.4.2.3.3. Australia Market Size and Forecast, by Animal Type
8.4.2.3.4. Australia Market Size and Forecast, by Distribution Channel
8.4.2.4. India
8.4.2.4.1. India Market Size and Forecast, by Product
8.4.2.4.2. India Market Size and Forecast, by Route of Administration
8.4.2.4.3. India Market Size and Forecast, by Animal Type
8.4.2.4.4. India Market Size and Forecast, by Distribution Channel
8.4.2.5. South Korea
8.4.2.5.1. South Korea Market Size and Forecast, by Product
8.4.2.5.2. South Korea Market Size and Forecast, by Route of Administration
8.4.2.5.3. South Korea Market Size and Forecast, by Animal Type
8.4.2.5.4. South Korea Market Size and Forecast, by Distribution Channel
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific Market Size and Forecast, by Product
8.4.2.6.2. Rest of Asia-Pacific Market Size and Forecast, by Route of Administration
8.4.2.6.3. Rest of Asia-Pacific Market Size and Forecast, by Animal Type
8.4.2.6.4. Rest of Asia-Pacific Market Size and Forecast, by Distribution Channel
8.4.3. Asia-Pacific Market Size and Forecast, by Product
8.4.4. Asia-Pacific Market Size and Forecast, by Route of Administration
8.4.5. Asia-Pacific Market Size and Forecast, by Animal Type
8.4.6. Asia-Pacific Market Size and Forecast, by Distribution Channel
8.5. Lamea
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Analysis, by Country
8.5.2.1. Brazil
8.5.2.1.1. Brazil Market Size and Forecast, by Product
8.5.2.1.2. Brazil Market Size and Forecast, by Route of Administration
8.5.2.1.3. Brazil Market Size and Forecast, by Animal Type
8.5.2.1.4. Brazil Market Size and Forecast, by Distribution Channel
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia Market Size and Forecast, by Product
8.5.2.2.2. Saudi Arabia Market Size and Forecast, by Route of Administration
8.5.2.2.3. Saudi Arabia Market Size and Forecast, by Animal Type
8.5.2.2.4. Saudi Arabia Market Size and Forecast, by Distribution Channel
8.5.2.3. South Africa
8.5.2.3.1. South Africa Market Size and Forecast, by Product
8.5.2.3.2. South Africa Market Size and Forecast, by Route of Administration
8.5.2.3.3. South Africa Market Size and Forecast, by Animal Type
8.5.2.3.4. South Africa Market Size and Forecast, by Distribution Channel
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA Market Size and Forecast, by Product
8.5.2.4.2. Rest of LAMEA Market Size and Forecast, by Route of Administration
8.5.2.4.3. Rest of LAMEA Market Size and Forecast, by Animal Type
8.5.2.4.4. Rest of LAMEA Market Size and Forecast, by Distribution Channel
8.5.3. Lamea Market Size and Forecast, by Product
8.5.4. Lamea Market Size and Forecast, by Route of Administration
8.5.5. Lamea Market Size and Forecast, by Animal Type
8.5.6. Lamea Market Size and Forecast, by Distribution Channel
Chapter 9. Company Profiles
9.1. Archer Daniels Midland
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.2. Boehringer Ingelheim International GmbH
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Business Performance
9.3. Ceva Santé Animale
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Dechra Pharmaceuticals plc.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Business Performance
9.5. Elanco Animal Health Incorporated.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Business Performance.
9.5.6. Key Strategic Moves and Developments
9.6. Evonik Industries AG (Rag Stiftung)
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Business Performance
9.6.6. Key Strategic Moves and Developments
9.7. Merck & Co. Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.7.5. Business Performance
9.7.6. Key Strategic Moves and Developments
9.8. Soparfin Sca.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.8.5. Key Strategic Moves and Developments
9.9. Virbac Sa.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.9.5. Business Performance
9.9.6. Key Strategic Moves and Developments
9.10. Zoetis Inc.
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
9.10.5. Business Performance
9.10.6. Key Strategic Moves and Developments

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...